Zevra Therapeutics (ZVRA) Capital Leases (2014 - 2018)
Zevra Therapeutics (ZVRA) posted Capital Leases of $396000.0 for Q4 2018, down 12.2% on a QoQ basis from $451000.0 in Q3 2018, and down 29.54% year-over-year from $562000.0 in Q4 2017.
Zevra Therapeutics (ZVRA) Capital Leases (2014 - 2018) Analysis & Trends
Zevra Therapeutics' Capital Leases history runs 5 years deep, the most recent figure standing at $396000.0 for Q4 2018.
- Quarterly Capital Leases fell 29.54% year-over-year to $396000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $396000.0 (down 29.54% YoY) and the FY2018 annual result came in at $396000.0, down 29.54% from the prior year.
- Capital Leases was $396000.0 for Q4 2018 at Zevra Therapeutics, down from $451000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $657000.0 in Q4 2016 and bottomed at $3000.0 in Q3 2015.
- A 5-year average of $310500.0 and a median of $423500.0 in 2018 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2017 — Capital Leases decreased 14.46% — and 2018, when it fell 29.54%.
- Zevra Therapeutics' Capital Leases stood at $26000.0 in 2014, then tumbled by 88.46% to $3000.0 in 2015, then jumped by 21800.0% to $657000.0 in 2016, then fell by 14.46% to $562000.0 in 2017, then dropped by 29.54% to $396000.0 in 2018.
- Business Quant data shows ZVRA's Capital Leases at $396000.0 in Q4 2018, $451000.0 in Q3 2018, and $466000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 396,000.00 |
| Sep 30, 2018 | 451,000.00 |
| Jun 30, 2018 | 466,000.00 |
| Mar 31, 2018 | 515,000.00 |
| Dec 31, 2017 | 562,000.00 |
| Dec 31, 2016 | 657,000.00 |
| Sep 30, 2015 | 3,000.00 |
| Jun 30, 2015 | 11,000.00 |
| Mar 31, 2015 | 18,000.00 |
| Dec 31, 2014 | 26,000.00 |